| Symbol |
Name |
Standardized Value |
|
CD8A
|
CD8a molecule
|
4.0
|
|
FOXP3
|
forkhead box P3
|
4.0
|
|
CD4
|
CD4 molecule
|
4.0
|
|
IL10
|
interleukin 10
|
3.93
|
|
IFNG
|
interferon, gamma
|
3.853
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
3.827
|
|
TGFB1
|
transforming growth factor, beta 1
|
3.745
|
|
IL2
|
interleukin 2
|
3.726
|
|
CD274
|
CD274 molecule
|
3.712
|
|
IL4
|
interleukin 4
|
3.577
|
|
CD28
|
CD28 molecule
|
3.564
|
|
IL6
|
interleukin 6
|
3.548
|
|
TNF
|
tumor necrosis factor
|
3.486
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
3.473
|
|
PDCD1
|
programmed cell death 1
|
3.461
|
|
CD80
|
CD80 molecule
|
3.435
|
|
CD86
|
CD86 molecule
|
3.409
|
|
LAG3
|
lymphocyte-activation gene 3
|
3.384
|
|
IL1B
|
interleukin 1, beta
|
3.358
|
|
IL7R
|
interleukin 7 receptor
|
3.348
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
3.335
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
3.321
|
|
TBX21
|
T-box 21
|
3.317
|
|
IL13
|
interleukin 13
|
3.302
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
3.262
|
|
ICOS
|
inducible T-cell co-stimulator
|
3.258
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
3.245
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
3.236
|
|
IL5
|
interleukin 5
|
3.225
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
3.224
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
3.221
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
3.217
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
3.214
|
|
CD19
|
CD19 molecule
|
3.21
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
3.203
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
3.186
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
3.176
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
3.175
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
3.173
|
|
IL22
|
interleukin 22
|
3.169
|
|
SELL
|
selectin L
|
3.169
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
3.158
|
|
CD69
|
CD69 molecule
|
3.152
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
3.138
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
3.12
|
|
CD276
|
CD276 molecule
|
3.116
|
|
IL15
|
interleukin 15
|
3.111
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
3.102
|
|
LOC124905743
|
low affinity immunoglobulin gamma Fc region receptor III-B
|
3.089
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
3.085
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
3.085
|
|
GATA3
|
GATA binding protein 3
|
3.083
|
|
CD40LG
|
CD40 ligand
|
3.076
|
|
TLR4
|
toll-like receptor 4
|
3.046
|
|
CD27
|
CD27 molecule
|
3.044
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
3.043
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
3.041
|
|
IL1A
|
interleukin 1, alpha
|
3.025
|
|
IL7
|
interleukin 7
|
3.021
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
3.011
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
3.01
|
|
CD44
|
CD44 molecule (Indian blood group)
|
3.006
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
3.0
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
2.996
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
2.976
|
|
CCRL2
|
chemokine (C-C motif) receptor-like 2
|
2.976
|
|
IFNA1
|
interferon, alpha 1
|
2.974
|
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
2.962
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
2.951
|
|
TLR2
|
toll-like receptor 2
|
2.95
|
|
IL33
|
interleukin 33
|
2.949
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
2.948
|
|
IL18
|
interleukin 18
|
2.943
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
2.938
|
|
NCAM1
|
neural cell adhesion molecule 1
|
2.932
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
2.925
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
2.923
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
2.922
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
2.921
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
2.921
|
|
CLSTN1
|
calsyntenin 1
|
2.92
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
2.914
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
2.896
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
2.89
|
|
TLR9
|
toll-like receptor 9
|
2.878
|
|
IL9
|
interleukin 9
|
2.874
|
|
CD38
|
CD38 molecule
|
2.848
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
2.847
|
|
CD163
|
CD163 molecule
|
2.846
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
2.829
|
|
IL17F
|
interleukin 17F
|
2.826
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
2.821
|
|
RAG1
|
recombination activating gene 1
|
2.821
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
2.819
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
2.815
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
2.813
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
2.812
|
|
MRC1
|
mannose receptor, C type 1
|
2.806
|
|
TLR7
|
toll-like receptor 7
|
2.804
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
2.795
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
2.795
|
|
AHR
|
aryl hydrocarbon receptor
|
2.793
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
2.791
|
|
LOC102723996
|
ICOS ligand
|
2.791
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
2.79
|
|
RORC
|
RAR-related orphan receptor C
|
2.79
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
2.785
|
|
MYD88
|
myeloid differentiation primary response 88
|
2.783
|
|
IRF4
|
interferon regulatory factor 4
|
2.778
|
|
CD68
|
CD68 molecule
|
2.777
|
|
EGFR
|
epidermal growth factor receptor
|
2.777
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
2.773
|
|
TP53
|
tumor protein p53
|
2.769
|
|
ICAM1
|
intercellular adhesion molecule 1
|
2.759
|
|
ACKR2
|
atypical chemokine receptor 2
|
2.754
|
|
AOC3
|
amine oxidase, copper containing 3
|
2.753
|
|
CD1D
|
CD1d molecule
|
2.751
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
2.747
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
2.727
|
|
IL2RB
|
interleukin 2 receptor, beta
|
2.726
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
2.713
|
|
TLR3
|
toll-like receptor 3
|
2.713
|
|
BTLA
|
B and T lymphocyte associated
|
2.71
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
2.702
|
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1
|
2.696
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
2.694
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
2.692
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
2.687
|
|
CD83
|
CD83 molecule
|
2.683
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
2.682
|
|
TSLP
|
thymic stromal lymphopoietin
|
2.681
|
|
LGALS9C
|
lectin, galactoside-binding, soluble, 9C
|
2.678
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
2.668
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
2.668
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
2.66
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
2.657
|
|
CD247
|
CD247 molecule
|
2.654
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
2.643
|
|
MMP9
|
matrix metallopeptidase 9
|
2.642
|
|
AIRE
|
autoimmune regulator
|
2.63
|
|
PTEN
|
phosphatase and tensin homolog
|
2.628
|
|
JAK1
|
Janus kinase 1
|
2.625
|
|
RAG2
|
recombination activating gene 2
|
2.621
|
|
CD1C
|
CD1c molecule
|
2.62
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2.616
|
|
INS
|
insulin
|
2.615
|
|
ARG2
|
arginase 2
|
2.612
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
2.611
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
2.603
|
|
CD33
|
CD33 molecule
|
2.599
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
2.598
|
|
IL23R
|
interleukin 23 receptor
|
2.597
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
2.595
|
|
CD47
|
CD47 molecule
|
2.595
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
2.593
|
|
FBF1
|
Fas (TNFRSF6) binding factor 1
|
2.593
|
|
STAT4
|
signal transducer and activator of transcription 4
|
2.59
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
2.587
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
2.587
|
|
CD70
|
CD70 molecule
|
2.586
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
2.585
|
|
HMGB1
|
high mobility group box 1
|
2.584
|
|
LRRC32
|
leucine rich repeat containing 32
|
2.583
|
|
CD5
|
CD5 molecule
|
2.583
|
|
FFAR2
|
free fatty acid receptor 2
|
2.579
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
2.577
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
2.576
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
2.575
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
2.572
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
2.57
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
2.57
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
2.569
|
|
CD34
|
CD34 molecule
|
2.567
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
2.566
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
2.564
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
2.554
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
2.553
|
|
JAK2
|
Janus kinase 2
|
2.552
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
2.55
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
2.549
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
2.548
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
2.546
|
|
EOMES
|
eomesodermin
|
2.545
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
2.545
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
2.539
|
|
DDX53
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 53
|
2.537
|
|
CD226
|
CD226 molecule
|
2.535
|
|
BATF
|
basic leucine zipper transcription factor, ATF-like
|
2.535
|
|
HDAC9
|
histone deacetylase 9
|
2.534
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
2.53
|
|
NRP1
|
neuropilin 1
|
2.525
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
2.525
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
2.521
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
2.52
|
|
IL4R
|
interleukin 4 receptor
|
2.517
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
2.517
|
|
MPPE1
|
metallophosphoesterase 1
|
2.513
|
|
SMAD3
|
SMAD family member 3
|
2.506
|
|
IL1R1
|
interleukin 1 receptor, type I
|
2.506
|
|
IL6R
|
interleukin 6 receptor
|
2.504
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
2.498
|
|
SIRPA
|
signal-regulatory protein alpha
|
2.497
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
2.495
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
2.492
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
2.491
|
|
CTAG1B
|
cancer/testis antigen 1B
|
2.49
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
2.49
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
2.475
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
2.474
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.471
|
|
PVR
|
poliovirus receptor
|
2.468
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
2.464
|
|
THY1
|
Thy-1 cell surface antigen
|
2.461
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
2.46
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
2.46
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
2.458
|
|
TLR5
|
toll-like receptor 5
|
2.457
|
|
TLR8
|
toll-like receptor 8
|
2.457
|
|
TFRC
|
transferrin receptor
|
2.454
|
|
IL3
|
interleukin 3
|
2.454
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
2.453
|
|
ADORA2A
|
adenosine A2a receptor
|
2.45
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
2.442
|
|
CD24
|
CD24 molecule
|
2.441
|
|
JUN
|
jun proto-oncogene
|
2.441
|
|
CD209
|
CD209 molecule
|
2.437
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
2.434
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
2.429
|
|
CD2
|
CD2 molecule
|
2.429
|
|
CALR
|
calreticulin
|
2.426
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
2.426
|
|
FN1
|
fibronectin 1
|
2.426
|
|
EGF
|
epidermal growth factor
|
2.426
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
2.421
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
2.421
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
2.419
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
2.419
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
2.417
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
2.417
|
|
LY75-CD302
|
LY75-CD302 readthrough
|
2.416
|
|
TNFSF18
|
tumor necrosis factor (ligand) superfamily, member 18
|
2.412
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
2.411
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
2.408
|
|
IL33R
|
interleukin 33 receptor
|
2.405
|
|
CGAS
|
cyclic GMP-AMP synthase
|
2.404
|
|
JAK3
|
Janus kinase 3
|
2.403
|
|
FOXO1
|
forkhead box O1
|
2.4
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
2.4
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
2.397
|
|
IRF1
|
interferon regulatory factor 1
|
2.396
|
|
GZMK
|
granzyme K (granzyme 3; tryptase II)
|
2.391
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
2.39
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
2.387
|
|
PXDNL
|
peroxidasin-like
|
2.387
|
|
HCAR2
|
hydroxycarboxylic acid receptor 2
|
2.386
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
2.383
|
|
BATF3
|
basic leucine zipper transcription factor, ATF-like 3
|
2.383
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
2.381
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
2.379
|
|
GNLY
|
granulysin
|
2.377
|
|
NELFCD
|
negative elongation factor complex member C/D
|
2.377
|
|
SMAD2
|
SMAD family member 2
|
2.376
|
|
CD160
|
CD160 molecule
|
2.371
|
|
RIGI
|
RNA sensor RIG-I
|
2.37
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
2.368
|
|
TGFB2
|
transforming growth factor, beta 2
|
2.367
|
|
IL21R
|
interleukin 21 receptor
|
2.366
|
|
TTC4
|
tetratricopeptide repeat domain 4
|
2.366
|
|
IL17RA
|
interleukin 17 receptor A
|
2.366
|
|
IRF3
|
interferon regulatory factor 3
|
2.364
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
2.363
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
2.36
|
|
LTA
|
lymphotoxin alpha
|
2.358
|
|
VSIR
|
V-set immunoregulatory receptor
|
2.358
|
|
TLR1
|
toll-like receptor 1
|
2.356
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
2.353
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
2.351
|
|
SDC1
|
syndecan 1
|
2.351
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
2.35
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
2.348
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
2.347
|
|
MUC1
|
mucin 1, cell surface associated
|
2.346
|
|
IRF8
|
interferon regulatory factor 8
|
2.345
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
2.344
|
|
B2M
|
beta-2-microglobulin
|
2.343
|
|
FFAR3
|
free fatty acid receptor 3
|
2.343
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
2.342
|
|
LEP
|
leptin
|
2.342
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
2.339
|
|
ANXA5
|
annexin A5
|
2.339
|
|
IKZF4
|
IKAROS family zinc finger 4 (Eos)
|
2.338
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
2.338
|
|
CD52
|
CD52 molecule
|
2.333
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
2.33
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
2.329
|
|
MPO
|
myeloperoxidase
|
2.325
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
2.325
|
|
BCL2L1
|
BCL2-like 1
|
2.324
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
2.324
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
2.32
|
|
PRG2
|
proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein)
|
2.319
|
|
KDR
|
kinase insert domain receptor
|
2.318
|
|
EPCAM
|
epithelial cell adhesion molecule
|
2.317
|
|
ACKR4
|
atypical chemokine receptor 4
|
2.317
|
|
IFNA2
|
interferon, alpha 2
|
2.317
|
|
MMP2
|
matrix metallopeptidase 2
|
2.315
|
|
BCR
|
breakpoint cluster region
|
2.313
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
2.312
|
|
SCARB1
|
scavenger receptor class B, member 1
|
2.308
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
2.303
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
2.303
|
|
MSLN
|
mesothelin
|
2.302
|
|
APOE
|
apolipoprotein E
|
2.3
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
2.3
|
|
CD200
|
CD200 molecule
|
2.299
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
2.298
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
2.294
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
2.293
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
2.291
|
|
SCARB2
|
scavenger receptor class B, member 2
|
2.291
|
|
CLEC4C
|
C-type lectin domain family 4, member C
|
2.289
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
2.286
|
|
NKG7
|
natural killer cell granule protein 7
|
2.285
|
|
CCL7
|
chemokine (C-C motif) ligand 7
|
2.285
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
2.284
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
2.283
|
|
FGL2
|
fibrinogen-like 2
|
2.283
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
2.28
|
|
FGF7
|
fibroblast growth factor 7
|
2.276
|
|
HMOX1
|
heme oxygenase 1
|
2.271
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
2.269
|
|
CNOT6
|
CCR4-NOT transcription complex, subunit 6
|
2.268
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
2.268
|
|
CD8B
|
CD8b molecule
|
2.267
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
2.267
|
|
SYK
|
spleen tyrosine kinase
|
2.265
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
2.264
|
|
CD1B
|
CD1b molecule
|
2.264
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
2.263
|
|
IRF7
|
interferon regulatory factor 7
|
2.261
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
2.26
|
|
XCR1
|
chemokine (C motif) receptor 1
|
2.258
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
2.258
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
2.251
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
2.251
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
2.251
|
|
IFNGR1
|
interferon gamma receptor 1
|
2.251
|
|
TYK2
|
tyrosine kinase 2
|
2.246
|
|
CD207
|
CD207 molecule, langerin
|
2.246
|
|
IL27RA
|
interleukin 27 receptor, alpha
|
2.246
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
2.244
|
|
CISH
|
cytokine inducible SH2-containing protein
|
2.244
|
|
CLEC9A
|
C-type lectin domain family 9, member A
|
2.243
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
2.242
|
|
H2BC21
|
H2B clustered histone 21
|
2.242
|
|
NOTCH1
|
notch 1
|
2.241
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
2.241
|
|
HSPA4
|
heat shock 70kDa protein 4
|
2.236
|
|
ESR1
|
estrogen receptor 1
|
2.234
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
2.233
|
|
FLT3
|
fms-related tyrosine kinase 3
|
2.233
|
|
NECTIN2
|
nectin cell adhesion molecule 2
|
2.232
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
2.229
|
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
2.229
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
2.227
|
|
CD96
|
CD96 molecule
|
2.226
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
2.226
|
|
SELE
|
selectin E
|
2.226
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
2.225
|
|
XCL1
|
chemokine (C motif) ligand 1
|
2.225
|
|
RUNX1
|
runt-related transcription factor 1
|
2.225
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.224
|
|
SMAD4
|
SMAD family member 4
|
2.224
|
|
MAGEA3
|
melanoma antigen family A3
|
2.224
|
|
IRF5
|
interferon regulatory factor 5
|
2.224
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
2.224
|
|
THBD
|
thrombomodulin
|
2.223
|
|
RUNX3
|
runt-related transcription factor 3
|
2.223
|
|
CD58
|
CD58 molecule
|
2.219
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
2.219
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
2.218
|
|
SIRT1
|
sirtuin 1
|
2.217
|
|
TOX
|
thymocyte selection-associated high mobility group box
|
2.213
|
|
CD22
|
CD22 molecule
|
2.209
|
|
NAALADL1
|
N-acetylated alpha-linked acidic dipeptidase-like 1
|
2.206
|
|
NANOS2
|
nanos homolog 2 (Drosophila)
|
2.205
|
|
ERVFRD-1
|
endogenous retrovirus group FRD, member 1
|
2.201
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
2.2
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
2.199
|
|
ENG
|
endoglin
|
2.198
|
|
ERV3-1
|
endogenous retrovirus group 3, member 1
|
2.198
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
2.198
|
|
CD1E
|
CD1e molecule
|
2.193
|
|
FOXP2
|
forkhead box P2
|
2.192
|
|
CARD11
|
caspase recruitment domain family, member 11
|
2.192
|
|
CD9
|
CD9 molecule
|
2.189
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
2.188
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
2.185
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
2.183
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
2.182
|
|
IL21
|
interleukin 21
|
2.177
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
2.177
|
|
IL26
|
interleukin 26
|
2.173
|
|
MSR1
|
macrophage scavenger receptor 1
|
2.169
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
2.169
|
|
FLT1
|
fms-related tyrosine kinase 1
|
2.168
|
|
ACE2
|
angiotensin I converting enzyme 2
|
2.167
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
2.166
|
|
CDK4
|
cyclin-dependent kinase 4
|
2.164
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
2.163
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
2.162
|
|
TGFB3
|
transforming growth factor, beta 3
|
2.161
|
|
FOXO3
|
forkhead box O3
|
2.16
|
|
IL11
|
interleukin 11
|
2.158
|
|
AXL
|
AXL receptor tyrosine kinase
|
2.158
|
|
DPP4
|
dipeptidyl-peptidase 4
|
2.158
|
|
IFNA17
|
interferon, alpha 17
|
2.158
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
2.157
|
|
CD81
|
CD81 molecule
|
2.157
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
2.156
|
|
CD63
|
CD63 molecule
|
2.155
|
|
SATB1
|
SATB homeobox 1
|
2.153
|
|
SPI1
|
Spi-1 proto-oncogene
|
2.152
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
2.146
|
|
CD200R1
|
CD200 receptor 1
|
2.143
|
|
FGF9
|
fibroblast growth factor 9
|
2.143
|
|
SIGLEC1
|
sialic acid binding Ig-like lectin 1, sialoadhesin
|
2.142
|
|
FGF10
|
fibroblast growth factor 10
|
2.141
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
2.141
|
|
THBS1
|
thrombospondin 1
|
2.141
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
2.139
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
2.139
|
|
FGF5
|
fibroblast growth factor 5
|
2.139
|
|
FGF3
|
fibroblast growth factor 3
|
2.138
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
2.138
|
|
FGF18
|
fibroblast growth factor 18
|
2.136
|
|
CCND1
|
cyclin D1
|
2.136
|
|
FGF16
|
fibroblast growth factor 16
|
2.135
|
|
PROM1
|
prominin 1
|
2.135
|
|
FGF4
|
fibroblast growth factor 4
|
2.134
|
|
PPBP
|
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
|
2.133
|
|
FGF6
|
fibroblast growth factor 6
|
2.132
|
|
SLTM
|
SAFB-like, transcription modulator
|
2.131
|
|
FGF20
|
fibroblast growth factor 20
|
2.131
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
2.131
|
|
CHAMP1
|
chromosome alignment maintaining phosphoprotein 1
|
2.13
|
|
FGF22
|
fibroblast growth factor 22
|
2.13
|
|
FGF17
|
fibroblast growth factor 17
|
2.129
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
2.128
|
|
C5AR1
|
complement component 5a receptor 1
|
2.125
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.125
|
|
CEP70
|
centrosomal protein 70kDa
|
2.122
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
2.122
|
|
CREB1
|
cAMP responsive element binding protein 1
|
2.121
|
|
RETNLB
|
resistin like beta
|
2.119
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
2.118
|
|
TLR6
|
toll-like receptor 6
|
2.117
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
2.116
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
2.116
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
2.114
|
|
IL10RB
|
interleukin 10 receptor, beta
|
2.113
|
|
LDHA
|
lactate dehydrogenase A
|
2.113
|
|
SNAI1
|
snail family zinc finger 1
|
2.111
|
|
BAX
|
BCL2-associated X protein
|
2.111
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
2.11
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
2.109
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
2.106
|
|
IL37
|
interleukin 37
|
2.106
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
2.105
|
|
JAG1
|
jagged 1
|
2.105
|
|
OCLN
|
occludin
|
2.104
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
2.102
|
|
VEGFC
|
vascular endothelial growth factor C
|
2.101
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
2.101
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
2.101
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
2.101
|
|
SMAD7
|
SMAD family member 7
|
2.1
|
|
C3
|
complement component 3
|
2.1
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
2.099
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
2.098
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
2.097
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
2.094
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
2.094
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
2.091
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
2.091
|
|
KLF2
|
Kruppel-like factor 2
|
2.088
|
|
IL18R1
|
interleukin 18 receptor 1
|
2.088
|
|
CXCL3
|
chemokine (C-X-C motif) ligand 3
|
2.088
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
2.088
|
|
KITLG
|
KIT ligand
|
2.088
|
|
IL13RA2
|
interleukin 13 receptor, alpha 2
|
2.086
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
2.086
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
2.084
|
|
ATM
|
ATM serine/threonine kinase
|
2.084
|
|
TBK1
|
TANK-binding kinase 1
|
2.083
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
2.082
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
2.082
|
|
TJP1
|
tight junction protein 1
|
2.081
|
|
H3C7
|
H3 clustered histone 7
|
2.079
|
|
EP300
|
E1A binding protein p300
|
2.078
|
|
TARP
|
TCR gamma alternate reading frame protein
|
2.078
|
|
SELPLG
|
selectin P ligand
|
2.077
|
|
GZMH
|
granzyme H (cathepsin G-like 2, protein h-CCPX)
|
2.077
|
|
TIMD4
|
T-cell immunoglobulin and mucin domain containing 4
|
2.077
|
|
LTF
|
lactotransferrin
|
2.077
|
|
MMP3
|
matrix metallopeptidase 3
|
2.076
|
|
AGXT
|
alanine-glyoxylate aminotransferase
|
2.074
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
2.072
|
|
AIM2
|
absent in melanoma 2
|
2.072
|
|
H3-4
|
H3.4 histone, cluster member
|
2.072
|
|
EPAS1
|
endothelial PAS domain protein 1
|
2.071
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
2.071
|
|
H3C13
|
H3 clustered histone 13
|
2.07
|
|
H3-7
|
H3.7 histone (putative)
|
2.069
|
|
IL27
|
interleukin 27
|
2.068
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
2.068
|
|
H3-5
|
H3.5 histone
|
2.068
|
|
PKM
|
pyruvate kinase, muscle
|
2.067
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
2.067
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
2.066
|
|
STK11
|
serine/threonine kinase 11
|
2.065
|
|
ELANE
|
elastase, neutrophil expressed
|
2.064
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
2.063
|
|
MALT1
|
MALT1 paracaspase
|
2.06
|
|
MCL1
|
myeloid cell leukemia 1
|
2.059
|
|
IFNA4
|
interferon, alpha 4
|
2.059
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
2.058
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
2.055
|
|
CD48
|
CD48 molecule
|
2.054
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
2.047
|
|
TNFSF14
|
tumor necrosis factor (ligand) superfamily, member 14
|
2.047
|
|
IFNA13
|
interferon, alpha 13
|
2.047
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
2.046
|
|
ANXA1
|
annexin A1
|
2.044
|
|
IFNA5
|
interferon, alpha 5
|
2.043
|
|
SLAMF7
|
SLAM family member 7
|
2.043
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
2.04
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
2.039
|
|
IFNA8
|
interferon, alpha 8
|
2.037
|
|
LOX
|
lysyl oxidase
|
2.036
|
|
IFNA7
|
interferon, alpha 7
|
2.035
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
2.035
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
2.034
|
|
MUC16
|
mucin 16, cell surface associated
|
2.033
|
|
CLTA
|
clathrin, light chain A
|
2.033
|
|
IFNA10
|
interferon, alpha 10
|
2.033
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
2.032
|
|
IFNA21
|
interferon, alpha 21
|
2.03
|
|
IFNA6
|
interferon, alpha 6
|
2.03
|
|
IFNA14
|
interferon, alpha 14
|
2.03
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
2.029
|
|
METTL3
|
methyltransferase like 3
|
2.028
|
|
LAYN
|
layilin
|
2.027
|
|
IFNA16
|
interferon, alpha 16
|
2.027
|
|
PTPN2
|
protein tyrosine phosphatase, non-receptor type 2
|
2.026
|
|
GPR15
|
G protein-coupled receptor 15
|
2.023
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
2.023
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
2.022
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
2.02
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
2.019
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
2.019
|
|
IL32
|
interleukin 32
|
2.016
|
|
TERT
|
telomerase reverse transcriptase
|
2.015
|
|
BRCA1
|
breast cancer 1, early onset
|
2.014
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
2.013
|
|
CTSS
|
cathepsin S
|
2.011
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
2.01
|
|
TMIGD2
|
transmembrane and immunoglobulin domain containing 2
|
2.009
|
|
IL16
|
interleukin 16
|
2.008
|
|
MMP1
|
matrix metallopeptidase 1
|
2.007
|
|
PF4
|
platelet factor 4
|
2.006
|
|
PLCG1
|
phospholipase C, gamma 1
|
2.004
|
|
LMNA
|
lamin A/C
|
2.003
|
|
FGL1
|
fibrinogen-like 1
|
2.003
|
|
AICDA
|
activation-induced cytidine deaminase
|
2.001
|
|
IL25
|
interleukin 25
|
1.999
|
|
TNFSF8
|
tumor necrosis factor (ligand) superfamily, member 8
|
1.996
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
1.995
|
|
CRLF2
|
cytokine receptor-like factor 2
|
1.993
|
|
ITGA1
|
integrin, alpha 1
|
1.992
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.991
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
1.991
|
|
LCN2
|
lipocalin 2
|
1.99
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
1.99
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.99
|
|
ITK
|
IL2-inducible T-cell kinase
|
1.989
|
|
POSTN
|
periostin, osteoblast specific factor
|
1.988
|
|
CD7
|
CD7 molecule
|
1.988
|
|
GCG
|
glucagon
|
1.984
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
1.983
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
1.982
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
1.982
|
|
PRTN3
|
proteinase 3
|
1.981
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.981
|
|
IL1R2
|
interleukin 1 receptor, type II
|
1.979
|
|
PDPN
|
podoplanin
|
1.978
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.978
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
1.978
|
|
C3AR1
|
complement component 3a receptor 1
|
1.978
|
|
WT1
|
Wilms tumor 1
|
1.977
|
|
SLAMF6
|
SLAM family member 6
|
1.977
|
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin)
|
1.975
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
1.975
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.975
|
|
IL31
|
interleukin 31
|
1.974
|
|
SLC44A4
|
solute carrier family 44, member 4
|
1.974
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
1.974
|
|
CARD9
|
caspase recruitment domain family, member 9
|
1.973
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
1.972
|
|
NFIL3
|
nuclear factor, interleukin 3 regulated
|
1.972
|
|
ZBTB7B
|
zinc finger and BTB domain containing 7B
|
1.971
|
|
HDAC1
|
histone deacetylase 1
|
1.971
|
|
XBP1
|
X-box binding protein 1
|
1.968
|
|
TRAF3
|
TNF receptor-associated factor 3
|
1.967
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
1.967
|
|
ULBP1
|
UL16 binding protein 1
|
1.967
|
|
ITGB7
|
integrin, beta 7
|
1.964
|
|
RBP3
|
retinol binding protein 3, interstitial
|
1.963
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
1.961
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
1.961
|
|
RETN
|
resistin
|
1.96
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
1.96
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
1.96
|
|
IZUMO1R
|
IZUMO1 receptor, JUNO
|
1.959
|
|
MKI67
|
marker of proliferation Ki-67
|
1.959
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
1.958
|
|
TGFA
|
transforming growth factor, alpha
|
1.958
|
|
S100A4
|
S100 calcium binding protein A4
|
1.957
|
|
SPDL1
|
spindle apparatus coiled-coil protein 1
|
1.956
|
|
GAD2
|
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
|
1.953
|
|
BDNF
|
brain-derived neurotrophic factor
|
1.951
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
1.951
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.95
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.95
|
|
ANGPT2
|
angiopoietin 2
|
1.95
|
|
CCN2
|
cellular communication network factor 2
|
1.948
|
|
ALDH1A2
|
aldehyde dehydrogenase 1 family, member A2
|
1.947
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
1.946
|
|
LTB
|
lymphotoxin beta (TNF superfamily, member 3)
|
1.946
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.941
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
1.94
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
1.938
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.936
|
|
BSG
|
basigin (Ok blood group)
|
1.936
|
|
PGF
|
placental growth factor
|
1.936
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
1.935
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.932
|
|
RHOA
|
ras homolog family member A
|
1.931
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.929
|
|
NKTR
|
natural killer cell triggering receptor
|
1.929
|
|
CYCS
|
cytochrome c, somatic
|
1.929
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
1.927
|
|
TYR
|
tyrosinase
|
1.926
|
|
DOCK8
|
dedicator of cytokinesis 8
|
1.925
|
|
ICAM3
|
intercellular adhesion molecule 3
|
1.923
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
1.922
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
1.922
|
|
CADM1
|
cell adhesion molecule 1
|
1.922
|
|
IL24
|
interleukin 24
|
1.921
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
1.92
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
1.92
|
|
ACE
|
angiotensin I converting enzyme
|
1.919
|
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1
|
1.918
|
|
LIF
|
leukemia inhibitory factor
|
1.917
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
1.917
|
|
CCM2
|
cerebral cavernous malformation 2
|
1.917
|
|
IL34
|
interleukin 34
|
1.917
|
|
CLDN1
|
claudin 1
|
1.916
|
|
MX1
|
MX dynamin-like GTPase 1
|
1.915
|
|
TG
|
thyroglobulin
|
1.912
|
|
STAB1
|
stabilin 1
|
1.912
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.912
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
1.911
|
|
FLG
|
filaggrin
|
1.911
|
|
EGR2
|
early growth response 2
|
1.909
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.909
|
|
PGR
|
progesterone receptor
|
1.908
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
1.907
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
1.906
|
|
CD101
|
CD101 molecule
|
1.906
|
|
FLG2
|
filaggrin family member 2
|
1.905
|
|
CLDN7
|
claudin 7
|
1.905
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
1.904
|
|
IL17RB
|
interleukin 17 receptor B
|
1.904
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
1.903
|
|
ANGPT1
|
angiopoietin 1
|
1.903
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
1.903
|
|
HDAC6
|
histone deacetylase 6
|
1.9
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
1.9
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
1.899
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
1.896
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
1.896
|
|
NOTCH2
|
notch 2
|
1.895
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
1.895
|
|
CLEC4G
|
C-type lectin domain family 4, member G
|
1.892
|
|
KCTD11
|
potassium channel tetramerization domain containing 11
|
1.892
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
1.89
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
1.889
|
|
ADA
|
adenosine deaminase
|
1.889
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
1.887
|
|
AREG
|
amphiregulin
|
1.886
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
1.885
|
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3
|
1.885
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
1.885
|
|
ATG5
|
autophagy related 5
|
1.884
|
|
GPC3
|
glypican 3
|
1.883
|
|
IL17C
|
interleukin 17C
|
1.883
|
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|
1.883
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
1.882
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
1.882
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
1.881
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
1.881
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
1.88
|
|
DLL4
|
delta-like 4 (Drosophila)
|
1.88
|
|
CPAMD8
|
C3 and PZP-like, alpha-2-macroglobulin domain containing 8
|
1.879
|
|
HDAC3
|
histone deacetylase 3
|
1.878
|
|
IFNL1
|
interferon, lambda 1
|
1.878
|
|
IL6ST
|
interleukin 6 signal transducer
|
1.877
|
|
HHLA2
|
HERV-H LTR-associating 2
|
1.876
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
1.875
|
|
HSPB3
|
heat shock 27kDa protein 3
|
1.875
|
|
BECN1
|
beclin 1, autophagy related
|
1.874
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
1.874
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
1.874
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
1.874
|
|
YTHDF1
|
YTH N(6)-methyladenosine RNA binding protein 1
|
1.874
|
|
MMP7
|
matrix metallopeptidase 7
|
1.871
|
|
SH2D1A
|
SH2 domain containing 1A
|
1.87
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
1.868
|
|
MAGEA1
|
melanoma antigen family A1
|
1.867
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
1.867
|
|
GSDMD
|
gasdermin D
|
1.866
|
|
FCRL3
|
Fc receptor-like 3
|
1.866
|
|
FOXP1
|
forkhead box P1
|
1.865
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
1.864
|
|
CLEC6A
|
C-type lectin domain family 6, member A
|
1.864
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.864
|
|
PRKCQ
|
protein kinase C, theta
|
1.863
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
1.862
|
|
HOOK2
|
hook microtubule-tethering protein 2
|
1.862
|
|
SLC30A10
|
solute carrier family 30, member 10
|
1.862
|
|
ULBP2
|
UL16 binding protein 2
|
1.862
|
|
BST2
|
bone marrow stromal cell antigen 2
|
1.862
|
|
DEFB4A
|
defensin, beta 4A
|
1.861
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
1.861
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
1.861
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
1.861
|
|
IL19
|
interleukin 19
|
1.86
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
1.86
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
1.859
|
|
TREM1
|
triggering receptor expressed on myeloid cells 1
|
1.859
|
|
TMC6
|
transmembrane channel-like 6
|
1.858
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.857
|
|
MMP12
|
matrix metallopeptidase 12
|
1.856
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
1.854
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
1.854
|
|
KIR2DL4
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
|
1.854
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
1.852
|
|
RET
|
ret proto-oncogene
|
1.852
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.851
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
1.851
|
|
MLH1
|
mutL homolog 1
|
1.851
|
|
CLEC4E
|
C-type lectin domain family 4, member E
|
1.85
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
1.849
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
1.846
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
1.846
|
|
FBXO8
|
F-box protein 8
|
1.844
|
|
CDPF1
|
cysteine-rich, DPF motif domain containing 1
|
1.842
|
|
ALKBH5
|
AlkB family member 5, RNA demethylase
|
1.841
|
|
MSH2
|
mutS homolog 2
|
1.84
|
|
NLRC4
|
NLR family, CARD domain containing 4
|
1.839
|
|
IRAK3
|
interleukin-1 receptor-associated kinase 3
|
1.835
|
|
TSG101
|
tumor susceptibility 101
|
1.835
|
|
CA9
|
carbonic anhydrase IX
|
1.833
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
1.832
|
|
SLC16A4
|
solute carrier family 16, member 4
|
1.832
|
|
NCOR2
|
nuclear receptor corepressor 2
|
1.832
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
1.832
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
1.831
|
|
CD84
|
CD84 molecule
|
1.829
|
|
YTHDF2
|
YTH N(6)-methyladenosine RNA binding protein 2
|
1.827
|
|
IL17RC
|
interleukin 17 receptor C
|
1.826
|
|
CTSG
|
cathepsin G
|
1.825
|
|
VWF
|
von Willebrand factor
|
1.825
|
|
SIGLEC15
|
sialic acid binding Ig-like lectin 15
|
1.825
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
1.825
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
1.825
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
1.825
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
1.824
|
|
YAP1
|
Yes-associated protein 1
|
1.824
|
|
HCST
|
hematopoietic cell signal transducer
|
1.823
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
1.822
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
1.82
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.82
|
|
SNAI2
|
snail family zinc finger 2
|
1.82
|
|
NANOG
|
Nanog homeobox
|
1.819
|
|
HDAC2
|
histone deacetylase 2
|
1.819
|
|
AMBP
|
alpha-1-microglobulin/bikunin precursor
|
1.819
|
|
FGF13
|
fibroblast growth factor 13
|
1.818
|
|
AIF1
|
allograft inflammatory factor 1
|
1.817
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
1.817
|
|
ZC3H13
|
zinc finger CCCH-type containing 13
|
1.817
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
1.817
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
1.816
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
1.816
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
1.816
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.815
|
|
IRF9
|
interferon regulatory factor 9
|
1.815
|
|
METTL14
|
methyltransferase like 14
|
1.814
|
|
ERLN
|
endoregulin
|
1.813
|
|
LY96
|
lymphocyte antigen 96
|
1.812
|
|
BRCA2
|
breast cancer 2, early onset
|
1.812
|
|
EPHA2
|
EPH receptor A2
|
1.811
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.81
|
|
GPX4
|
glutathione peroxidase 4
|
1.81
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
1.809
|
|
TRAF1
|
TNF receptor-associated factor 1
|
1.808
|
|
ATG7
|
autophagy related 7
|
1.808
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.807
|
|
PTK2
|
protein tyrosine kinase 2
|
1.807
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
1.807
|
|
IL4I1
|
interleukin 4 induced 1
|
1.805
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
1.805
|
|
REG3A
|
regenerating islet-derived 3 alpha
|
1.804
|
|
FABP5
|
fatty acid binding protein 5 (psoriasis-associated)
|
1.803
|
|
ZNF683
|
zinc finger protein 683
|
1.803
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.802
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
1.802
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
1.802
|
|
EBI3
|
Epstein-Barr virus induced 3
|
1.8
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
1.8
|
|
APOB
|
apolipoprotein B
|
1.797
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.797
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
1.797
|
|
TLR10
|
toll-like receptor 10
|
1.796
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.796
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
1.795
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
1.795
|
|
WTAP
|
Wilms tumor 1 associated protein
|
1.795
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.795
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
1.794
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
1.793
|
|
IL17B
|
interleukin 17B
|
1.793
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
1.793
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
1.792
|
|
GAS6
|
growth arrest-specific 6
|
1.791
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
1.791
|
|
SHH
|
sonic hedgehog
|
1.79
|
|
PAX5
|
paired box 5
|
1.79
|
|
DLAT
|
dihydrolipoamide S-acetyltransferase
|
1.789
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
1.788
|
|
PSMA7
|
proteasome (prosome, macropain) subunit, alpha type, 7
|
1.787
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
1.787
|
|
GPR183
|
G protein-coupled receptor 183
|
1.784
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
1.784
|
|
CD6
|
CD6 molecule
|
1.784
|
|
GRB2
|
growth factor receptor-bound protein 2
|
1.784
|
|
S100A8
|
S100 calcium binding protein A8
|
1.783
|
|
THPO
|
thrombopoietin
|
1.783
|
|
CTSB
|
cathepsin B
|
1.781
|
|
EDN1
|
endothelin 1
|
1.781
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.781
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
1.781
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.779
|
|
MCAM
|
melanoma cell adhesion molecule
|
1.779
|
|
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5
|
1.779
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.779
|
|
FOLR2
|
folate receptor 2 (fetal)
|
1.779
|
|
POMC
|
proopiomelanocortin
|
1.779
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
1.778
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
1.777
|
|
MS4A4A
|
membrane-spanning 4-domains, subfamily A, member 4A
|
1.777
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.775
|
|
POTEF
|
POTE ankyrin domain family, member F
|
1.774
|
|
YTHDC1
|
YTH domain containing 1
|
1.774
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
1.773
|
|
TAPBP
|
TAP binding protein (tapasin)
|
1.773
|
|
KYNU
|
kynureninase
|
1.772
|
|
CREM
|
cAMP responsive element modulator
|
1.771
|
|
PSCA
|
prostate stem cell antigen
|
1.771
|
|
MSH6
|
mutS homolog 6
|
1.77
|
|
MMP13
|
matrix metallopeptidase 13
|
1.769
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
1.769
|
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4
|
1.769
|
|
RIPK3
|
receptor-interacting serine-threonine kinase 3
|
1.768
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
1.768
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
1.767
|
|
CLEC4A
|
C-type lectin domain family 4, member A
|
1.767
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
1.767
|
|
DROSHA
|
drosha, ribonuclease type III
|
1.766
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
1.766
|
|
NOTCH3
|
notch 3
|
1.765
|
|
SIGLEC10
|
sialic acid binding Ig-like lectin 10
|
1.765
|
|
DNAH8
|
dynein, axonemal, heavy chain 8
|
1.764
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
1.763
|
|
XCL2
|
chemokine (C motif) ligand 2
|
1.763
|
|
LEPROT
|
leptin receptor overlapping transcript
|
1.762
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.761
|
|
GPR83
|
G protein-coupled receptor 83
|
1.761
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
1.758
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
1.758
|
|
CMA1
|
chymase 1, mast cell
|
1.758
|
|
PLG
|
plasminogen
|
1.756
|
|
GDF15
|
growth differentiation factor 15
|
1.755
|
|
RARA
|
retinoic acid receptor, alpha
|
1.754
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
1.754
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
1.753
|
|
INSR
|
insulin receptor
|
1.752
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
1.752
|
|
WAS
|
Wiskott-Aldrich syndrome
|
1.752
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
1.752
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
1.751
|
|
FGFBP2
|
fibroblast growth factor binding protein 2
|
1.751
|
|
PLAU
|
plasminogen activator, urokinase
|
1.75
|
|
NTAN1
|
N-terminal asparagine amidase
|
1.75
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
1.75
|
|
UNK
|
unkempt family zinc finger
|
1.75
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.75
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
1.749
|
|
MREG
|
melanoregulin
|
1.749
|
|
VCAN
|
versican
|
1.749
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
1.748
|
|
C5AR2
|
complement component 5a receptor 2
|
1.747
|
|
AFDN
|
afadin, adherens junction formation factor
|
1.747
|
|
IRF2
|
interferon regulatory factor 2
|
1.746
|
|
PBRM1
|
polybromo 1
|
1.746
|
|
YTHDC2
|
YTH domain containing 2
|
1.745
|
|
EGR1
|
early growth response 1
|
1.741
|
|
FASN
|
fatty acid synthase
|
1.74
|
|
GLMN
|
glomulin, FKBP associated protein
|
1.74
|
|
ATP4A
|
ATPase, H+/K+ exchanging, alpha polypeptide
|
1.74
|
|
IL1F10
|
interleukin 1 family, member 10 (theta)
|
1.74
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
1.739
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
1.739
|
|
CDK1
|
cyclin-dependent kinase 1
|
1.739
|
|
IL9R
|
interleukin 9 receptor
|
1.738
|
|
FOXN1
|
forkhead box N1
|
1.737
|
|
PIGR
|
polymeric immunoglobulin receptor
|
1.737
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
1.736
|
|
DHX58
|
DEXH (Asp-Glu-X-His) box polypeptide 58
|
1.736
|
|
H2AC1
|
H2A clustered histone 1
|
1.736
|
|
ULBP3
|
UL16 binding protein 3
|
1.735
|
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
1.735
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
1.734
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
1.734
|
|
APP
|
amyloid beta (A4) precursor protein
|
1.734
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
1.733
|
|
INSM2
|
insulinoma-associated 2
|
1.733
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
1.733
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
1.732
|
|
TSC22D3
|
TSC22 domain family, member 3
|
1.732
|
|
FTO
|
fat mass and obesity associated
|
1.731
|
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region
|
1.731
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
1.73
|
|
ITGB8
|
integrin, beta 8
|
1.73
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
1.73
|
|
VIRMA
|
vir like m6A methyltransferase associated
|
1.73
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
1.729
|
|
BRD4
|
bromodomain containing 4
|
1.729
|
|
ATF3
|
activating transcription factor 3
|
1.729
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
1.729
|
|
LYZ
|
lysozyme
|
1.728
|
|
NFKBID
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta
|
1.728
|
|
TRIM21
|
tripartite motif containing 21
|
1.724
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
1.724
|
|
C1D
|
C1D nuclear receptor corepressor
|
1.723
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
1.722
|
|
IL17D
|
interleukin 17D
|
1.722
|
|
MMP8
|
matrix metallopeptidase 8
|
1.721
|
|
CDC42
|
cell division cycle 42
|
1.721
|
|
GPX3
|
glutathione peroxidase 3
|
1.721
|
|
XPR1
|
xenotropic and polytropic retrovirus receptor 1
|
1.72
|
|
ZBTB46
|
zinc finger and BTB domain containing 46
|
1.72
|
|
MFGE8
|
milk fat globule-EGF factor 8 protein
|
1.719
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
1.719
|
|
YTHDF3
|
YTH N(6)-methyladenosine RNA binding protein 3
|
1.719
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
1.716
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
1.715
|
|
IGF2
|
insulin-like growth factor 2
|
1.714
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
1.714
|
|
CLEC12A
|
C-type lectin domain family 12, member A
|
1.714
|
|
PVRIG
|
poliovirus receptor related immunoglobulin domain containing
|
1.714
|
|
GPX2
|
glutathione peroxidase 2
|
1.714
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
1.713
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
1.712
|
|
NCR3LG1
|
natural killer cell cytotoxicity receptor 3 ligand 1
|
1.711
|
|
TPO
|
thyroid peroxidase
|
1.711
|
|
NF1
|
neurofibromin 1
|
1.711
|
|
HNRNPA2B1
|
heterogeneous nuclear ribonucleoprotein A2/B1
|
1.71
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
1.709
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.709
|
|
VEGFD
|
vascular endothelial growth factor D
|
1.709
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
1.708
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.708
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
1.706
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
1.705
|
|
BHLHE40
|
basic helix-loop-helix family, member e40
|
1.704
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.703
|
|
RBM15B
|
RNA binding motif protein 15B
|
1.703
|
|
SPHK1
|
sphingosine kinase 1
|
1.703
|
